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Results
The net costs and incremental costs per DALY averted for a range of vaccination costs were presented in tables. The vaccination programme reduced disability and resulted in cost savings when the vaccination costs were less than $55 per child for simulation A, and $70 for simulation B, with 5% annual decline in vaccine efficacy.
For simulation A at a vaccination cost of $60, the programme resulted in expected costs of $1,500,000 in the whole cohort of 250,000 children, and generated an incremental cost-effectiveness ratio (ICER) of $15,000 per DALY averted. For simulation B at a vaccination cost of $80, the programme resulted in expected costs of $590,000 in the whole cohort of 50,000 children, and generated an ICER of $25,830 per DALY averted.
The sensitivity analysis indicated that the most influential model inputs were the utility estimates, age weighting, health care costs, and vaccination costs.
